Clinical Trial

A Pharmacokinetic Study of D-2570 in Participants With Hepatic Impairment and Normal Hepatic Function

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a single-center, non-randomized, open-label, parallel-group study. It will test D-2570 in people with liver problems and in people with healthy livers, to see how the drug moves through the body and whether it is safe.
Trial Details
NCT Number NCT07715149
Lead Sponsor InventisBio Co., Ltd
Conditions Healthy Adult Participants, Hepatic Impairment (HI)
Enrollment 24 participants
Start Date 2026-07-14
Primary Completion 2026-10-31 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-20